| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Research and development | $15.2M+5.2% | $14.5M-8.7% | $15.9M+89.9% | $8.3M |
| General and administrative | $7.9M-18.9% | $9.7M-56.2% | $22.2M+280.2% | $5.8M |
| Total operating expenses | $23.1M-4.5% | $24.2M-36.4% | $38.1M+168.3% | $14.2M |
| Loss from operations | -$23.1M+4.5% | -$24.2M+36.4% | -$38.1M-168.3% | -$14.2M |
| Change in fair value of financial instruments | -$6.0M-163.2% | $9.5M+199.6% | $3.2M | — |
| Interest expense | -$1.4M | $0 | — | — |
| Interest income | $713K-29.7% | $1.0M | — | — |
| Other income | $268K | $0-100.0% | $550K+2064.3% | -$28K |
| Total other income (expense) | -$6.4M-161.3% | $10.5M+182.5% | $3.7M-41.6% | $6.4M |
| Net loss | -$29.6M-115.8% | -$13.7M+60.1% | -$34.4M-339.1% | -$7.8M |
| Net loss per share - basic | -$1970.00-61.5% | -$1220.00+84.1% | -$7660.00+93.1% | -$111160.00 |
| Net loss per share - diluted | -$1970.00-61.5% | -$1220.00+84.1% | -$7660.00+93.1% | -$111160.00 |
| Weighted-average number of shares outstanding used in computing net loss per share - basic | $15011321000.00+33.5% | $11245915000.00+150.7% | $4486258000.00+5354.7% | $82245000.00 |
| Weighted-average number of shares outstanding used in computing net loss per share - diluted | $15011321000.00+33.5% | $11245915000.00+150.7% | $4486258000.00+5354.7% | $82245000.00 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.